Memantine is an uncompetitive NMDA antagonsit with a really long half-life (60-100 hours). I read some old threads here and experience reports on erowid, but I didn't find enough information to decide if it's worth trying or not.
Check these if you're interested:
http://www.bluelight.ru/vb/threads/306985-More-about-Memantine
http://www.erowid.org/experiences/exp.php?ID=32398
From Wikipedia:
It has the same binding site like magnesium, but it has a higher affinity. Therefore it blocks the Ca2+ influx by NMDA activation when a pathologically high dose of glutamate is released, but when there's a lower concentration of glutamate, memantine can't bind to the channel and allows the normal ion influx, so it doesn't disrupt so aggressively the NMDA dependent neurotransmission like non-competitive antagonists (ketamine).
Memantine is also a dopamine D2 receptor agonist, 5-HT3 receptor and Alpha-7 nAChR antagonist.